Tango Therapeutics (TNGX) Net Margin (2020 - 2025)
Historic Net Margin for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to 29.52%.
- Tango Therapeutics' Net Margin rose 2808100.0% to 29.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 151.09%, marking a year-over-year increase of 1333100.0%. This contributed to the annual value of 309.73% for FY2024, which is 311900.0% down from last year.
- Tango Therapeutics' Net Margin amounted to 29.52% in Q3 2025, which was up 2808100.0% from 1221.41% recorded in Q2 2025.
- Tango Therapeutics' Net Margin's 5-year high stood at 29.52% during Q3 2025, with a 5-year trough of 1221.41% in Q2 2025.
- For the 5-year period, Tango Therapeutics' Net Margin averaged around 411.75%, with its median value being 419.8% (2022).
- As far as peak fluctuations go, Tango Therapeutics' Net Margin soared by 2886200bps in 2023, and later crashed by -10928500bps in 2025.
- Tango Therapeutics' Net Margin (Quarter) stood at 385.83% in 2021, then fell by -18bps to 454.0% in 2022, then fell by -25bps to 566.19% in 2023, then tumbled by -61bps to 913.99% in 2024, then skyrocketed by 103bps to 29.52% in 2025.
- Its Net Margin stands at 29.52% for Q3 2025, versus 1221.41% for Q2 2025 and 739.54% for Q1 2025.